Listen to ASX-listed Memphasys Executive Chair Alison Coutts talk to Matt Birney on the Bulls N’ Bears Report about Memphasys’ very first clinical order for its remarkable IVF treatment device.

Listen to ASX-listed Coda Minerals CEO Chris Stevens talk to Matt Birney on the Bulls N’ Bears Report about Coda’s third serious new copper equivalent resource.

Listen to ASX-listed Venture Minerals Managing Director Andrew Radonjic talk to Matt Birney on the Bulls N’ Bears Report about Venture’s extraordinarily long tin/tungsten drill hit that comes at a time when the price of tin per tonne is blitzing both copper and nickel.

Listen to ASX-listed Impact Minerals Managing Director Mike Jones talk to Matt Birney on the Bulls N’ Bears Report about Impact’s new suite of nickel/copper/platinum/lithium projects and the mega miner who will spend $18m farming into another of its projects.

Listen to ASX-listed Kalamazoo Resources Executive Chairman Luke Reinehr talk to Matt Birney on the Bulls N’ Bears Report about Kalamazoo’s multi-million dollar farm-in deal with one of the world’s largest lithium producers.

Listen to ASX-listed Arovella Therapeutics Managing Director Dr Michael Baker talk to Matt Birney on the Bulls N’ Bears Report about Arovella’s amazing technology that can temporarily remove blood cells from the body and reprogram them to seek and destroy cancer cells before being reinserted.